This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08620/identifier/pdb/
n13http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB08620/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08620/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08620/identifier/drugbank/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB08620/identifier/chemspider/

Statements

Subject Item
n2:DB08620
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB08620 n14:DB08620
dcterms:title
{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide
adms:identifier
n6:103099 n8:115224 n9:99445091 n10:DB08620 n11:TH4
n3:IUPAC-Name
n4:271B4381-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4387-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4386-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4383-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4384-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4385-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B437F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4380-363D-11E5-9242-09173F13E4C5 n4:271B437D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B437E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B438D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B438E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4388-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4389-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B438B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B438A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B438C-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4392-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4394-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4395-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4391-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4390-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4393-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4382-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B438F-363D-11E5-9242-09173F13E4C5